Pall Biotech

Join us for the next webinar in the

Industrializing Gene Therapy
Webinar Series

Webinar On Demand! Register to watch now!

60 Minutes


Viral vectors for gene therapy have shown tremendous clinical promise which has spurred a huge increase in demand for manufacturing space, resulting in a capacity crisis. This is currently delaying the commercialization of these gene therapies for which time to market is critical.

Integrated solutions for viral vectors designed within modular cleanroom facilities streamline manufacturing and reduce time to market. Pall Biotech and G-CON manufacturing have partnered to design and deploy an integrated manufacturing solution to address the current capacity constraints for viral vector manufacturing.

Participants will learn:

  1. The manufacturing challenges facing the viral vector industry
  2. The advantages of an integrated manufacturing solution
  3. How to develop and deploy a new manufacturing facility in 10 months within a modular cleanroom


  • Moderator:

    Dr. Clive Glover

    Pall Biotech
    Director, Cell & Gene Therapy

  • Presenter:

    Jeremy Rautenbach 

    Pall Biotech
    Global Product Manager, Integrated Solutions

  • Presenter:

    Dr. Joseph Rininger

    Latham BioPharm Group
    Director, Cell & Gene Therapy

  • Presenter:

    Peter Makowensky

    G-CON Manufacturing
    Director, Sales Engineering

Register & Watch Now!

All fields required